Indirubin, an Active Component of Indigo Naturalis, Exhibits Inhibitory Effects onLeukemia Cells via Targeting HSP90AA1 and PI3K/Akt Pathway

IND, an active component of Indigo Naturalis, could inhibit CML progression, which may be achieved via inhibiting HSP90AA1 and PI3K/Akt signaling expression levels.